Treprostinil Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
UTHR | B | United Therapeutics Corporation | -0.10 | |
LQDA | D | Liquidia Technologies, Inc. | -3.39 | |
ASND | F | Ascendis Pharma A/S | -1.28 |
Related Industries: Biotechnology
Related Stock Lists:
Hypertension
Pulmonary Arterial Hypertension
Biotechnology
Life Sciences
Alcohol
Biopharmaceutical
Blastoma
Brain Cancer
Breakthrough Therapy
Bupivacaine
Chemical Compounds
Chronic And Life Threatening Conditions
Clinical Trial
Diabetes
Disease
Drug Therapies
Growth Hormone
Growth Hormone Deficiency
Growth Hormone Therapy
Hepatitis C
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
MEDI | D | Harbor Health Care ETF | 17.02 | |
PBE | B | PowerShares Dynamic Biotech & Genome | 5.84 | |
FTXH | D | First Trust Nasdaq Pharmaceuticals ETF | 3.92 | |
PJP | C | PowerShares Dynamic Pharmaceuticals | 3.71 | |
FBT | B | First Trust Amex Biotech Index Fund | 3.67 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Hypertension
Pulmonary Arterial Hypertension
Biotechnology
Life Sciences
Alcohol
Biopharmaceutical
Blastoma
Brain Cancer
Breakthrough Therapy
Bupivacaine
Chemical Compounds
Chronic And Life Threatening Conditions
Clinical Trial
Diabetes
Disease
Drug Therapies
Growth Hormone
Growth Hormone Deficiency
Growth Hormone Therapy
Hepatitis C
- Treprostinil
Treprostinil (marketed under the trade names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation) is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil is a synthetic analog of prostacyclin (PGI2).
The inhaled form of treprostinil was approved by the FDA in July 2009 and is marketed as the trade name Tyvaso.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles